Federal Register #2026-21360

DEA Registration Application for Scottsdale Research Institute to Manufacture Ibogaine for Research

The Department of Justice’s Drug Enforcement Administration is considering Scottsdale Research Institute’s application to manufacture ibogaine for research and clinical trials. - Notice type: Regulatory registration notice, not a procurement solicitation or contract award. - Government agency: U.S. Department of Justice (DOJ), Drug Enforcement Administration (DEA). - Applicant: Scottsdale Research Institute seeks registration as a bulk manufacturer of ibogaine, a controlled substance. - Proposed activity: Manufacture ibogaine for the institute’s internal research and to support clinical trials; no other activity involving ibogaine is authorized under the proposed registration. - Procurement items and quantities: No products or services are being purchased, and no quantities or part numbers are specified. - Eligible parties: Registered bulk manufacturers and applicants may submit comments or objections, or request a hearing.

Description

Scottsdale Research Institute applied to be registered as a bulk manufacturer of ibogaine, a basic class of controlled substance. The company plans to manufacture the substance for internal research purposes and to support clinical trials; no other activity for this drug code is authorized under the registration. Eligible registered bulk manufacturers and applicants may submit comments or objections, or request a hearing, by December 18, 2026.

View original listing